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Seclusion and enforced medication in dealing with Aggression: a prospective dynamic 
cohort study  
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Abstract 
 
Background. In the Netherlands, seclusion is historically the measure of first choice in dealing 
with aggressive incidents. In 2010, the Mediant Mental Health Trust in Eastern Netherlands 
introduced a policy prioritising the use of enforced medication to manage aggressive 
incidents over seclusion. The main goal of the study was to investigate whether prioritising 
enforced medication over seclusion leads to a change of aggressive incidents and coercive 
measures.  
Methods. The study was carried out with data from 2764 patients admitted between 2007 and 
2013 to the hospital locations of the Mediant Mental Health Trust in Eastern Netherlands, 
with a catchment area of 500000 inhabitants. Seclusion, restraint and enforced medications as 
well as other coercive measures were gathered systematically. Aggressive incidents were 
assessed with the SOAS-R. An event sequence analysis was preformed, to assess the whether 
seclusion, restraint or enforced medication were used or not before or after aggressive 
incidents.  
Results. Enforced medication use went up by 363% from a very low baseline. There was a 
marked reduction of overall coercive measures by 44%. Seclusion hours went down by 62%. 
Aggression against staff was reduced by 40%.  
Conclusions. When dealing with aggression, prioritising medication significantly reduces 
other coercive measures and aggression against staff, while within principles of subsidiarity, 
proportionality and expediency. 
 
Original research - Word count abstract : 209; text: 3498 
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Introduction  
 The use of seclusion in dealing with aggression is increasingly perceived as an 
undesirable measure in dealing with aggression. From 2005 onwards the Dutch government 
spent more than 30 million euros in projects designed to reduce seclusion [1]. In several 
evaluations of Dutch mental health legislation and services [2-4] as well as in the opinion of 
policy makers [5] seclusion use was too abundant in dealing with aggression. In 2012 the 
Dutch government stated that any reduction of seclusion should not lead to substitution of 
seclusion by other measures [6]. At the same time studies showed that Dutch psychiatric 
patients do not have any particular preference for seclusion or enforced medication on 
average [7]. Recently, the UN special rapporteur on torture stated treatment against a patients 
consent in  psychiatry may be seen as torture [8], adding to the controversy and leading to 
political discussions and changes of law over Europe.  
 In Dutch law, a doctor is required to evaluate the necessity of using coercive 
measures case by case and to carefully weigh the impact of measures taken against the 
background of three major principles: subsidiarity, proportionality and expediency [9]:  
1. Subsidiarity: a more intrusive measure is only allowed when a lesser intrusive 
measure is insufficient to prevent danger;  
2. Proportionality: the measure needs to be proportionate to the extent of the danger. 
The infringement on autonomy, and specifically the infringement of the bodily 
integrity of the patient, should not exceed the danger the patient may pose to 
others. The safety of the measure should be weighed against the risks to others if no 
action is taken. In the Netherlands, the psychiatrist must document which efforts 
were taken to ensure the patients’ rights.  
3. Expediency: the treatment or measure must have proven efficacy in dealing with the 
 
5 
 
danger the patient poses. 
After introduction of the Dutch Mental Health Act in 1994 several evaluations proved a 
substantial increase in number and duration of seclusion time and incidents[2, 10]. Primarily 
due to the law prioritising the protection of a patient’s bodily integrity over his or her 
mental integrity, the Mental Health Act led to seclusion becoming the measure of first choice 
in dealing with aggression in the Netherlands[11]. Nevertheless, no evidence underpins the 
therapeutic effect of seclusion [12]. The Dutch Mental Health Act provides a legal basis for 
admission but not treatment. In general, medication is offered to the patient, but commonly 
refused. During an admission, weeks can therefore pass without medication treatment 
despite clear symptomatology and a sometimes dormant danger level. Only Article 39 of the 
Dutch Mental Health Act allows short acting enforced medication in case of immediate 
danger.  To deal with danger, seclusion was increasingly used in psychiatry[3, 10] and 
included up to 87% of all coercive measures in Dutch psychiatry. This had only reduced to 
82% by 2013 [13]. Enforced medication covered approximately 12% of the measures [14, 15].  
At the same time a substantial increase in involuntary admissions was observed [1]. Over 
the past few years, seclusion figures have reduced in line with international consensus in a 
minority of Dutch mental health institutes, however the major trends showed increasing 
differences of seclusion use amongst Dutch psychiatric hospitals [15]. Dutch national data 
show 75% of enforced medication is administered before, during or just after seclusion. 
Enforced medication is given in connection of only 20% of seclusion episodes, although the 
combination of seclusion with enforced medication nearly halves seclusion duration [14].  
 Mediant is a Mental Health Trust in the Eastern part of the Netherlands at the 
German border. It provides services for a population of around 500,000. It includes urban 
and rural areas. In 2010, Mediant changed their policy with regard to the use of coercive 
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measure from the use of seclusion as first choice in the management of aggression to a 
prioritization of enforced medication as coercive measure of first choice. With this policy, 
Mediant Mental Health Trust differed completely from other institutes in the Netherlands 
who continued to use seclusion as first choice and rare use of enforced medication [9, 14]. 
The policy was based on the principles of subsidiarity, proportionality and expediency, with 
an emphasis on providing evidence based treatments to patient. Whilst seclusion may 
reduce danger for the time being, it does not treat the cause of danger, which may include 
the psychiatric disorder of the patient. Enforced medication has some impact on the bodily 
integrity of the patient, but will often treat the underlying cause of danger. By starting with 
medication as coercive measure of first choice, seclusion may not be necessary or 
substantially shortened [14].  
  Both in the Netherlands and internationally, evidence is increasing showing 
interventions in dealing with aggression as seclusion, restraint or enforced medication vary 
largely between Mental Health Trusts [4, 14-18], and most certainly more than between 
countries [13]. In the Netherlands, such figures vary ten to twentyfold between hospitals, a 
difference that cannot be explained by variation in the severity of patients admitted [15]. In 
general, in the Netherlands, seclusion is used five times more often than enforced medication. 
Only a few Trusts follow international guidelines preferring enforced medication above 
seclusion, even though neither Dutch law nor Dutch guidelines prescribe a measure of first 
choice.  
 Ward policy in dealing with aggression may be supported by continuous assessment 
by means of the staff observation and aggression scale (SOAS-R) [19]. This instrument is 
internationally used to document aggressive incidents. It is used to assess both the nature and 
severity of aggression. Severe aggressive incidents have an important negative impact on 
 
7 
 
staff health and disrupt patient-staff interaction for some time.  
 No data exists with regard to the effect of a complete policy change in favour of 
enforced medication over seclusion. Our study examines the effect of the application of 
enforced medication as a measure of first choice on the number of aggression incidents as 
well as on the use of coercive measures.  
 
Methods  
 The current study describes seven year follow up data of a single Mental Health Trust. 
From 2007 onwards coercive measures have been documented by using the Argus scale [10], 
which comprehensively covers all coercive measures. Aggressive incidents were assessed by 
means of the SOAS-R. The policy change happened in 2010, near to a year after a change of 
hospital directors. patients. If a patient’s presentation implied that medication would 
probably be inevitable, enforced medication was the measure of first choice. In unknown 
patients enforced antipsychotic medication continued to be given reluctantly. In these patients 
sedation without antipsychotic medication was the first choice. In known patients haloperidol 
became the medication of first choice, when necessary accompanied by promethazine of 
lorazepam [21]. The majority of patients treated at Mediant (above 80%) had relapsing 
episodes of mental illness and were well known to services.  
 Setting. The study was carried out across two hospital locations in the east of the 
Netherlands, with a total of 217 beds. 75 of these beds are admission ward beds, 62 beds are 
long stay and 80 are for specialized treatment such as non-congenital brain disorders and 
psychiatry for elderly adults. 
Argus dataset. The Argus dataset covers coercive measures as counters and patient 
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background data as denominators [10 , 14]. For this study the database covered all available 
Argus data from this hospital from January 1st 2007 up till December 31st, 2013, leaving out 
admission days of patients admitted before or after these dates. The Argus coercive 
measures scale defines three main measures [10]:  
1. Seclusion is defined as bringing the patient into a locked room where he/she is alone 
and able to move around. The patient is unable to leave due to a locked door.  
2. Mechanical and manual restraint is defined as immobilizing the patient with external 
mechanical devices or physical force.  
3. Enforced medication is defined as the application of intramuscular medication by 
force against the patient’s will.  In addition, medication administered under 
psychological pressure is registered, allowing comparisons with international data 
[18, 22-24]. 
Aggression was measured with SOAS-R [19]. The SOAS allows a differentiated view of the 
severity of aggression. The inter-observer reliability of the scale was found to be satisfactory 
(Nijman,, 1997) with a correlation between observers of 0.87 and a kappa of 0.61, indicating 
fair to good agreement (Lambert and Hill, 1991). The SOAS-R was completed about each 
incident when a member of staff was subjected to an aggressive incident. The use of SOAS-R 
as a monitoring instrument has been part of daily practice from 2006 onwards. We included 
all aggression incidents either with verbal or physical means used by the patient. 
  The current article primarily focuses on substituting one intervention with 
another, while controlling for patient’s diagnosis and aggression. Despite the fact that 
politicians and policy makers point out that substitution of one coercive measure with 
another is not allowed [6], a clear definition is not provided. In the current article we 
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defined substitution in line with the international literature [12] , as follows:  
1. Substitution implies the replacement of one coercive measure with another.  
2. To allow comparison of time in seclusion with time of medication efficacy, the 
number of days a patient was subjected to a coercive measure was counted. It 
was assumed that applying intramuscular haloperidol with or without a 
benzodiazepine remains active in the patient for three days. This is a deliberately 
generous interpretation of the half-life of the medication in order to avoid 
accusations of trying to minimise its effect. In the case of depot medication 
(seldom used against a patient’s will) the efficacy was set at three weeks.  
 Patient background data. The database covered patient characteristics such as gender, 
date of birth, marital status, ethnicity, diagnosis (ICD-10) and Global Assessment of 
Functioning  (GAF) scores allowing international comparisons.  
 Design and statistical analysis. This study is a longitudinal dynamic cohort study 
comparing findings to nationwide data.  Two exposure periods were defined, before and 
after the policy change in 2010. Firstly, to obtain an impression of the population, the 
exposure to aggression, seclusion and enforced medication was calculated over the first 
three years (2007-2009) and over the last three years (2011-2013). For this analysis we 
aggregated admissions to a patient level. In this stratified database, patients admitted in 
both timeframes occurred twice. Furthermore, we constructed a database at a day to day 
intervention level. Patient characteristics were identified in both databases but the wards 
where interventions occurred only in the intervention level database.  
 In the analysis the number of started seclusions and aggression incidents were used 
as counters together with time spent in seclusion. Admission time and the population 
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number of the catchment area were used as denominators. In the same way time in seclusion 
or the numbers of days having been subjected to medication were used as counters whilst 
admission time of a patient in a year was used as numerators.  These figures were compared 
with nationwide figures calculated in the same way.  
 Events sequences were counted by looking to moments in time when aggression 
occurred or decisions to seclude or administer enforced medication were made. The 
sequences of one measure following another were counted, over a number of categories. 
Differences between years were tested by means of chi-square or student-test when 
appropriate.  A full listing of all variables and underlying calculations is presented in table 1.  
 
Table 1 about here 
 
 Possible confounding factors by patient or ward characteristics were investigated in 
three ways, correcting for patient characteristics before and after policy change. We 
performed a logistic regression on seclusion and a linear regression on the log of seclusion 
time per admission time on the patient level database. In the intervention level database we 
performed a mixed models repeated measures analysis, nested by ward, on seclusion 
duration. In all these analyses admission duration was included as an exposure variable. 
Findings of these analyses are reported only within the context of case mix correction.   
 An analysis of variance was performed to identify possible differences or similarities 
in trends between the Trust and the nationwide databases. As the nationwide databases 
were received anonymously, and patients could not be followed over years for that 
comparison case mix correction was not feasible. 
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Results 
 Table 2 describes the patient population at risk of coercive measures throughout the 
years examined. The table shows some substantial differences before and after the policy 
change, within the total population and within specific patient groups. The percentage of 
patients or staff subjected to aggression, seclusion or enforced medication all decreased by 
27 - 45%. In F2 (schizophrenia, schizotypal and delusional disorder) and F6 (Personality 
disorders) the most changes were seen, with the number of patients being aggressive, the 
number of patients secluded and the number of patients receiving enforced medication all 
substantially reducing after the policy change in 2010.  
 
Table 2 about here 
 
 Table 2 compared the several coercive measures to the number of admissions and 
admission time. The main finding was a clear decrease in seclusion time over the years 
examined (-62%) was accompanied by a clear increase (+363%) of days being subjected to 
enforced medication. However, importantly, the number of days patients were subjected to 
any type of coercion per 1,000 admission days reduced by 43%. Looking at the number of 
aggression incidents we observed a reduction of 40%. Putting these data into a nationwide 
Dutch perspective, the seclusion hours per 1,000 admission hours were clearly above the 
nationwide figure at Mediant before the policy change. After the policy change the coercion 
data were clearly below nationwide average data.  
 An analysis of variance on the aggregated figures presented in table 2 showed no 
significant differences between the investigated Trust and nationwide trends of medication 
events per admission days and seclusion hours per admission hours. The trends on 
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seclusions per inhabitants did show a significantly steeper decrease in the nationwide data 
(f=6.46; p=0.04). However, the investigated Trust started lower and ended lower.   
 The multivariate logistic regression analysis showed that policy (OR before-after: 
0,51, p=<0.000), more admission days (1,02, p=<0.000), male gender (OR 1,51, p=<0.000), 
young age (OR=1.31, p=0.090), having no partner (OR=1,41; p=0.007), ethnic origin 
(OR=1,65, p=0.004), neurotic disorders (OR=0,427, p<0.001), psychotic disorder (OR=2.02, 
p<0.000), and organic disorders (OR=1,54, p,0.025) were associated with an increased 
chance of being secluded. The linear regression revealed similar variables to be associated 
with seclusion hours per admission hours, namely the policy change (standardized β=-
0.112; p=0.006), no partner (standardized β=0.097; p=0.019), psychotic disorder 
(standardized β=0.225; p=0.002), mood disorder (standardized β=0.131; p=0.031), 
personality disorder (standardized β=-0.145; p=0.026), organic disorder (standardized β=-
0.112; p=0.012), and the number of admission days (standardized β=0.403; p<0.000). As 
table 1 shows, most of these variables are consistently distributed before and after the 
policy change. Two variables occur differently in the before and after sample: After the 
policy change there were more patients diagnosed with substance misuse disorders and 
less with personality disorders. However, substance misuse disorder occurred in a low 
number of patients, whereas personality disorder was inversely associated with the 
logarithm of hours in seclusion per admission hours. The multilevel analysis confirmed 
these findings with inverse associations of the policy change (OR=0.41, p<0.001), neurotic 
disorder (OR==0.58, p,0.001)  and personality disorder (0.38, p<0.001) to seclusion duration 
at an intervention level and positive associations of miscellaneous disorders (unknown 
patients; OR=7.69, p<0.001), substance abuse (OR=10 p<0.001), and psychosis (OR=4.34, 
p<0.001). Medication and aggression were not included in the regression analyses due to 
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collinearity.   
 
Table 3 about here 
 
 Looking at the number of times in which measures were started and aggressive 
incidents were followed or preceded either by seclusion or enforced medication incidents, 
we observed some striking changes: Before the policy change 645 incidents of seclusion 
occurred without any other measure. After the policy change this went down to 427. 
Seclusion as the first measure remained stable at 31 and 32 events respectively. Medication 
was first given in combination with seclusion in 112 events before the policy change and 43 
after. Most importantly, medication as the only coercive measure went up from 20 before to 
193 events after the policy change. All measures also reduced from 1044 to 818. The 
number of aggression incidents occurring in direct relation to coercion reduced from 228 to 
135 over the three examined years before and after the policy change respectively. 
Aggression incidents without a coercive response reduced from 1342 to 822 incidents.  
  
Discussion 
 Our data suggests that prioritising enforced medication over seclusion as first choice 
strategy to manage aggression is feasible. After the policy change almost 37% of coercive 
measures were medication in contrast to around 13% in the rest of the Netherlands. From a 
Dutch perspective involuntary medication use in the investigated Trust was high. With 9% of 
all admitted patients subjected to involuntary medication, it was nearly four times as high as 
expected, considering the Dutch nationwide data. This is comparable with Norwegian, 
Danish and English data, although with a prevalence of 2.6% of all admitted patients being 
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subjected to involuntary medication (Noorthoorn et al, 2015), the Netherlands are at the 
lower end of European data for coercive medication use. The Dutch data compares 
favourably to German findings, where an involuntary medication exposure prevalence of 
1.6% was reported (Flammer et al 2013). However, overall prevalence of exposure to any 
involuntary coercive measure during a psychiatric admission is very similar in Wales, 
Ireland and Germany with around 5.5%, but higher in the Netherlands with 9.4% (Lepping et 
al, 2016). 
 The data showed that prioritising medication over seclusion led to the expected 
increase in the use of medication but also a significant reduction in seclusion times and 
incidents as well as a reduction of aggression on staff. Concerns by nurses that using less 
seclusion may be more risky for the ward environment were not substantiated by our data. 
The findings show that a conscious decision to start medication treatment without delay can 
lead to important shifts in ratio figures lessening the need for seclusion whilst also reducing 
the total amount of coercion. The total coercive incidents diminished by more than half, 
when we look at change over time.  This study additionally shows a secondary reduction in 
the number of aggression incidents following the policy change. Starting prompt treatment 
not only reduces seclusion incidents, but also overall seclusion times.  
 Two studies have examined preferences for coercive measures amongst the Dutch 
patient population [6, 10]. 50% of the patients surveyed preferred enforced medication over 
seclusion with the other 50% preferring seclusion.  In a more recent clinical trial Georgieva 
et al. [24] showed that when medication is used as a measure of first choice, seclusion 
duration reduced by up to 75%. This was despite the fact that the number of times enforced 
medication was given did not differ between experimental and control wards in that study. 
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However, the experimental wards had significantly shorter average lengths of stay. This 
shows that medication use can have an effect on seclusion incidents and times, aggression 
and length of stay.  
 In Mediant the findings of the above studies were implemented in daily practice. 
When choosing coercive measures, the risks of enforced medication were balanced with the 
danger caused by the patient. Many patients were well known and had signed advanced 
directives in their medical charts allowing the use of enforced medication which were 
further encouraged. In the current study, not only duration, but also the number of 
incidents decreased. However, findings are difficult to compare, as the current study is an 
evaluation of treatment policy, supported by the medical director and team management. 
In contrast, the study by Georgieva is a clinical trial where teams were asked to comply 
with a study protocol with an experimental and a control ward. 
 The findings of this study show that a policy to use enforced medication as a 
measure of first choice in dealing with aggression not only leads to lower seclusion figures 
in a Dutch perspective, but also to fewer aggressive incidents and fewer total coercive 
measures. We argue that this is because the disorder of the patient is dealt with at an early 
stage of the admission. Of course, treating patients without coercion will always be 
preferable. Therefore, advanced directives and early risk assessment may support further 
reductions in the use of coercive measures.  
 A strength of the study is that we used the complete data of an entire mental health 
provider for a large area over a substantial number of years and a substantial number of 
patients. The policy change which is the focus of this study occurred in the middle year of 
our data collection, allowing to investigate the effect of this policy change, not only on 
seclusion findings, but also against the background of all coercive measures and admission 
Commented [P1]: Needs reference 
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data. At the same time the use of data of a single hospital is a limitation of the study. Other 
not measured organisational changes, such as implementation of the engagement model, 
working with experience workers, variations in personnel and slight changes of the 
environment could have had an effect. Variation in patient case mix was only controlled for 
in the hospitals’ sample, but not in the nationwide data. Also, it cannot be ruled out that 
single patients who were repeatedly coerced may have had a small effect on the final data. 
 Both Dutch [25, 26] and international studies [24, 27, 28] support choices made in this 
hospital. In order to implement such a policy change, support at a central level within an 
organisation is essential. It is important to ensure all professionals comply with the policy.   
 
Conclusion 
Prioritising enforced medication over seclusion as first line treatment for the management of 
aggression can reduce seclusion incidents and times as well as aggression, whilst operating 
within the principles of subsidiarity, proportionality and expediency. 
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Table 1  Patient compilation, aggression incidence, seclusion and enforced medication  
  before and after policy change 
Patient characteristics Before policy change After policy change Significant 
Difference* 
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Young 487 (35%) 9% 9% 4% 731 (40%) 6% 6% 3%  0.001 0.000 
Male patient  660 (47%) 11% 12% 4% 919 (50%) 6% 8% 3% 0.000 0.000  
No partner 939 (67%) 12% 10% 4% 1312 (71%) 12% 10% 4% 0.031 0.000 0.000 
Non-western descent  102 (7.3%) 2.1% 2.2% 1% 118 (6.4%) 1.6% 1.5% 1% 0.004 0.000  
No ICD – 10 diagnosis 43 (3%) 14% 9% 2% 66 (3.6% 15% 11% 4%    
F0 Organic disorders 110 (8%) 38% 19% 4% 189 (10.3% 23% 12% 2% 0.005   
F1 Disorders due to psychoactive substances 34 (2%) 14% 15%  91 (5%) 13% 9% 2%    
F2 Schizophrenia, schizotypal & delusional disorders 362 (26%) 30% 32% 17% 552 (30.1%) 22% 20% 11% 0.004 0.000 0.006 
F3 Mood disorders 160 (11,5%) 15% 27% 15% 340 (18.5%) 12% 11% 5%  0.000 0.000 
F4 Neurotic, disorders  101 (7.3%) 13% 9% 5% 92 (5%) 4% 2%     
F6 Personality disorders 507 (36.4%) 22% 16% 5% 429 (23.4%) 10% 8% 3% 0.000 0.000  
Below 40 GAF score 1392 38% 35% 29% 1836 28% 28% 11%    
All patients 1392 23% 22% 9% 1836 16% 13% 5% 0.000 0.000 0.000 
  * differences tested by means of chi square between the same item before and after.  
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Table 2 Seclusion and enforced medication compared to admissions and admission time   
 
 Before policy change  Implement
ation year 
After policy change  
Counters and denominators  
Medaint 2007-2013 
 
2007 
 
2008 
 
2009 
 
2010 
 
2011 
 
2012 
 
2013 
%∆   
Before and after  
Aggression incidents as measured with the SOAS-R 488 361 721 496 319 349 289 -40% 
Started seclusions* 383 301 282 281 219 364 193 -50% 
Patients admitted* 740 737 767 639 853 918 926 +20% 
Seclusions per 100 admissions per year** 52 41 37 44 26  39 21 -59% 
Seclusion days** 2131 1709 1124 901 855 356 711 -62% 
Seclusion hours** 54972 50183 36640 44435 25117 16259 12811 -62% 
Patients secluded* 128 114 110 91 108 102 89 -16% 
% patients exposed 17.2% 15.4% 14.3% 14.2% 12.6% 11.1% 9.6% -55% 
Days enforced medication / 100000 admission days 69 67 112 163 301 469 320 +363% 
Days coercion** 2194 1771 1228 1064 1156 752 1008 -44% 
Patients with enforced medication 48 59 57 59 49 45 39 -20% 
Admission days 91074 93030 93251 100047 100093 84397 92877 +1%  
Hours seclusion per 1000 admission hours** 25 22 16 19 10 8 6 
 
-62% 
Days coercion per 1000 admission days** 24 19 13 11 12 9 11 -43% 
Catchment area 392000 394200 398100 402100 405300 408100 409460 +4% 
Seclusions per 100000 inhabitants 0.97 0.76 0.70 0.69 0.54 0.89 0.47 -48% 
Nationwide data 2007 - 2013 
 
Da 
        
N admissions  9057 11130 21500 26686 42960 113290 100228  
% patients exposed 12.1 11.8 10.8 10.2 8.7 6.5 7.0 -40% 
Hours seclusion per 1000 admission hours 12.3 11.2 10.5 11.6 9.7 8.6 9.1 -25% 
Days enforced medication / 100000 admission days 57 72 99 105 135 138 243 +426% 
Number of seclusions 3186 3685 4750 5525 7476 9469 9802  
Catchment area 242800
0 
253500
0 
362400
0 
4563000 760500
0 
168584
78 
169751
44 
 
Seclusions per 100000 inhabitants 1.31 1.45 1.31 1.21 0.98 0.56 0.57 - 57% 
Event sequences 2007-2013***         
Seclusion only** 300 209 136 200 131 109 187 -36% 
Aggression preceded seclusion only** 58 23 17 11 28 9 29 -33% 
Seclusion followed by medication decisions*   6 7 13 48 11 6 15 +23% 
Medication decisions followed by seclusion** 29 32 51 23 25 5 13 -62% 
Aggression & med.  followed by seclusion   4 7 10 4 4 3 3 -53% 
Medication only decisions** 6 5 9 38 17 118 58 +865% 
Seclusion only followed by aggression**  25 22 45 4 9 3 11 -75% 
Aggression followed by seclusion  62 30 27 15 32 12 32 -36% 
*P<0,05  **P<0,001 ***Combinations of events occurring more than 20 times per 3 years are presented.  
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